Medications

Zurampic approved for gout

(HealthDay)—Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

Arthritis & Rheumatism

New classification criteria developed for gout

(HealthDay)—New classification criteria have been developed with high specificity and sensitivity for gout, according to an article published in the October issue of Arthritis & Rheumatology.

Arthritis & Rheumatism

New classification system developed for gout

A panel of experts and researchers have developed a new classification system for gout, the most common form of inflammatory arthritis. This new system standardizes the classification of this condition using a variety of ...

Arthritis & Rheumatism

Research backs belief that tomatoes can be a gout trigger

People who maintain that eating tomatoes can cause their gout to flare up are likely to welcome new University of Otago research that has, for the first time, found a biological basis for this belief.

Diseases, Conditions, Syndromes

Many patients with gout do not receive recommended treatment

Among patients in England with gout, only a minority of those with indications to receive urate-lowering therapy were treated according to guideline recommendations, according to a study in the December 24/31 issue of JAMA.

Arthritis & Rheumatism

ACR: Most hospitalizations for gout are preventable

(HealthDay)—Most hospitalizations for a primary diagnosis of gout are preventable, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 14 to 19 in Boston.

Diabetes

Gout linked to heightened diabetes risk

Gout is linked to a heightened risk of type 2 diabetes, suggests research published online in the Annals of the Rheumatic Diseases. The magnitude of the association seems to be significantly greater in women, among whom the ...

Arthritis & Rheumatism

Study finds gout drug may reduce risk of death

(Boston)—In a recently to be published study in Annals of the Rheumatic Diseases, researchers have found the use of the drug allopurinol was associated with a reduced risk of death in hyperuricemic (gout) patients. The ...

page 7 from 12